Target intelligence / Profile preview

Dopamine D1-like receptor family (D1-like receptors)

Target
D1-like receptors
Molecular classification
G protein-coupled receptor, Class A GPCR, Dopamine receptor
01

Overview

The D1-family dopamine receptors, comprising the D1 and D5 subtypes, are a class of G protein-coupled receptors (GPCRs) that play a fundamental role in the central nervous system and peripheral tissues (UniProt, 2023). These receptors are characterized by their coupling to stimulatory G proteins (Gs/olf), which activate adenylyl cyclase to increase intracellular cAMP levels, thereby modulating neuronal excitability and synaptic plasticity (StatPearls, 2024). In the brain, they are heavily involved in regulating motor activity, executive functions, and reward-related behaviors, while in the periphery, they contribute to the regulation of blood pressure and renal function (IUPHAR/BPS, 2023). Dysregulation of D1-family signaling is implicated in several neuropsychiatric and neurological conditions, including Parkinson's disease, schizophrenia, and ADHD (PubMed, 2022). Pharmacological targeting of these receptors involves agonists like fenoldopam for treating hypertension, as well as antagonists, often as part of a broader antipsychotic profile, to manage psychotic symptoms (PubChem, 2024). Understanding the distinct expression patterns and functional roles of D1 and D5 receptors remains a key area of research for developing more selective and effective therapeutic interventions (NIH, 2023).

Other names
D1-like dopamine receptorsD1-family receptorsD1 and D5 receptorsDRD1DRD5
02

Mechanism of action

D1-family receptors primarily couple to Gs or Golf proteins, which stimulate adenylyl cyclase activity, leading to an increase in the second messenger cyclic adenosine monophosphate (cAMP) and subsequent activation of protein kinase A (PKA) (StatPearls, 2024).

03

Biological functions

Signal transductionSynaptic plasticityMotor controlCognitive functionReward processingVasodilation
04

Disease associations

Parkinson's diseaseSchizophreniaAttention deficit hyperactivity disorderSubstance-related disordersHypertension
05

Safety considerations

Orthostatic hypotensionReflex tachycardiaDyskinesiaHallucinationsNausea
06

Interacting drugs

Fenoldopam

8 more in the full profile.

07

Biomarkers

Striatal D1 receptor density (via [11C]SCH23390 PET)Intracellular cAMP levelsDRD1 gene polymorphisms

Beyond the preview

Go deeper on Dopamine D1-like receptor family (D1-like receptors).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dopamine D1-like receptor family (D1-like receptors).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call